Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Ampicillin prices in Germany, the highest-cost reporting region, rose 8.0% in H1 2026, climbing from USD 53.7/KG in Q1 to USD 58.0/KG by Q2 as spring respiratory infection season pharmaceutical procurement and firmer 6-APA fermentation feedstock costs from Middle East supply disruptions drove consistent buying. Globally, the average rose from USD 38.50/KG in Q1 to USD 41.58/KG in Q2, an 8.0% gain. For H2 2026, a global average of USD 42.00-46.50/KG is expected, with continued firming on feedstock costs and growing bacterial infection treatment and veterinary pharmaceutical sector demand.
Ampicillin is a broad-spectrum aminopenicillin antibiotic produced through a semi-synthetic process combining fermentation-derived 6-aminopenicillanic acid, known as 6-APA, with a chemically synthesised D-phenylglycine side chain via enzymatic or chemical acylation. The 6-APA fermentation step relies on Penicillium chrysogenum fungal cultures grown on corn steep liquor and other fermentation nutrients, with subsequent enzymatic deacylation to remove the native penicillin side chain. The largest pull comes from pharmaceutical formulations for the oral and parenteral treatment of bacterial infections affecting the respiratory tract, urinary tract, gastrointestinal system, and skin and soft tissue, where ampicillin remains widely used in developing market antibiotic treatment protocols. Additional demand comes from veterinary antibiotic formulations for livestock respiratory and enteric infection treatment, combination products with beta-lactamase inhibitors such as sulbactam for hospital-acquired infection management, and generic pharmaceutical manufacturing for regulated and emerging market distribution. The 6-APA fermentation corn steep liquor substrate and phenylglycine synthesis costs, pharmaceutical and veterinary antibiotic sector demand, and regional semi-synthesis capacity all feed into the price.
The balance of supply and demand for ampicillin through H2 2026 leans moderately firm. Six-APA fermentation substrate and phenylglycine synthesis costs firmed from Middle East chemical supply chain disruptions. Pharmaceutical antibiotic formulation and veterinary sector demand is growing with expanding healthcare access across South and Southeast Asian markets.
The main upside risk is a sustained 6-APA fermentation and phenylglycine synthesis cost increase alongside accelerating antibiotic demand from bacterial infection prevalence. The main downside risk is continued Chinese ampicillin production surplus and competitive export pricing that limits the global price recovery.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 42.00 - 46.50 | Feedstock firming and antibiotic demand support |
| United States | 44.80 - 49.30 | Steady pharma and veterinary demand holds it firm |
| China | 29.00 - 33.50 | Large API capacity keeps it the most affordable |
| Germany | 55.00 - 59.50 | High synthesis and energy costs keep it the most expensive |
| India | 42.00 - 46.50 | Growing pharma and vet demand holds a firm middle |
US ampicillin prices averaged USD 47.9/KG in Q2 2026, up 8.1% from USD 44.3/KG in Q1 2026. Firmer 6-APA fermentation substrate and phenylglycine synthesis costs elevated production economics. Spring respiratory infection season pharmaceutical and veterinary procurement maintained consistent buying through the quarter.
Why did the price of Ampicillin change in Q2 2026 in the United States?
Firmer 6-APA fermentation substrate and phenylglycine synthesis costs raised the semi-synthetic production cost floor. Spring respiratory and urinary infection treatment procurement lifted buying from generic pharmaceutical formulators. Veterinary livestock antibiotic and ampicillin-sulbactam hospital combination product demand provided additional consistent buying support.
Chinese ampicillin prices averaged USD 30.5/KG in Q2 2026, up 7.8% from USD 28.3/KG in Q1 2026, the lowest among the tracked markets. Spring pharmaceutical formulation export procurement and domestic antibiotic seasonal demand lifted buying. Firmer domestic 6-APA and phenylglycine costs raised the production floor despite large domestic capacity.
Why did the price of Ampicillin change in Q2 2026 in China?
Spring pharmaceutical export procurement and domestic antibiotic seasonal demand lifted buying from domestic semi-synthesis producers. Firmer domestic 6-APA fermentation substrate and phenylglycine costs raised the production cost floor. Large domestic capacity kept China the most affordable source.
German ampicillin prices averaged USD 58.0/KG in Q2 2026, up 8.0% from USD 53.7/KG in Q1 2026, the highest among the tracked markets. Higher 6-APA, phenylglycine, and energy costs elevated European production economics. Consistent pharmaceutical, hospital combination, and veterinary demand maintained consistent buying.
Why did the price of Ampicillin change in Q2 2026 in Germany?
Higher 6-APA fermentation substrate, phenylglycine synthesis, and energy costs elevated European semi-synthesis economics. Middle East chemical supply disruptions added cost premiums to intermediate supply chains. Consistent pharmaceutical formulation, hospital injectable combination, and veterinary demand maintained consistent procurement.
Indian ampicillin prices averaged USD 44.1/KG in Q2 2026, up 8.1% from USD 40.8/KG in Q1 2026. Growing pharmaceutical formulation and veterinary demand supported buying. Firmer import-linked 6-APA and phenylglycine costs raised the production floor through the quarter.
Why did the price of Ampicillin change in Q2 2026 in India?
Growing pharmaceutical antibiotic formulation and veterinary livestock demand lifted procurement from domestic semi-synthesis producers. Firmer import-linked 6-APA fermentation substrate and phenylglycine costs raised the production floor. Middle East freight premiums elevated the landed cost of imported API intermediates.
US ampicillin prices averaged USD 44.3/KG in Q1 2026, declining modestly on the quarter. Post-winter antibiotic demand moderation and softer 6-APA costs reduced buying urgency near USD 44.3/KG.
Why did the price of Ampicillin change in Q1 2026 in the United States?
Post-winter respiratory infection season moderation reduced pharmaceutical procurement urgency. Softer 6-APA fermentation substrate costs eased the production floor. The market eased near USD 44.3/KG before the Q2 spring infection season recovery.
Chinese prices averaged USD 28.3/KG in Q1 2026, declining on the quarter. Post-Lunar New Year pharmaceutical export and seasonal demand moderation held the market near USD 28.3/KG.
Why did the price of Ampicillin change in Q1 2026 in China?
Post-Lunar New Year pharmaceutical export procurement moderation reduced buying urgency. Soft domestic 6-APA costs maintained comfortable production economics. Large domestic capacity maintained adequate supply near USD 28.3/KG.
German prices averaged USD 53.7/KG in Q1 2026, declining on the quarter. Post-winter pharmaceutical procurement moderation and softer 6-APA costs eased the market near USD 53.7/KG.
Why did the price of Ampicillin change in Q1 2026 in Germany?
Post-winter antibiotic and hospital procurement moderation reduced buying urgency. Softer 6-APA and phenylglycine costs eased the European production floor. The market eased near USD 53.7/KG before the Q2 spring infection season surge.
Indian prices averaged USD 40.8/KG in Q1 2026, declining modestly on the quarter. Post-holiday antibiotic demand moderation and softer import costs held the market near USD 40.8/KG.
Why did the price of Ampicillin change in Q1 2026 in India?
Post-holiday pharmaceutical and veterinary demand moderation reduced procurement urgency. Softer import-linked 6-APA and phenylglycine costs eased the production floor. The market eased near USD 40.8/KG before the Q2 spring demand recovery.
Global ampicillin prices showed a volatile alternating pattern through 2025 and H1 2026, with a Q3 2025 dip, a Q4 winter season restocking uptick, a Q1 2026 post-winter dip, and a strong Q2 2026 spring infection season surge. The average eased from USD 38.50/KG in Q2 2025 to USD 38.12/KG in Q3, recovered to USD 38.89/KG in Q4, eased to USD 38.50/KG in Q1 2026, then surged to USD 41.58/KG in Q2 2026, a net gain of about 8.0% over the window. Six-APA fermentation cost cycles and seasonal antibiotic demand patterns drove the alternating pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 41.58 | +8.0% | ↑ Rising |
| Q1 2026 | 38.50 | -1.0% | ↓ Falling |
| Q4 2025 | 38.89 | +2.0% | ↑ Rising |
| Q3 2025 | 38.12 | -1.0% | ↓ Falling |
| Q2 2025 | 38.50 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Ampicillin prices showed a broadly stable alternating pattern through 2025. The global average opened at USD 38.62/KG in Q1 2025 and closed near USD 38.89/KG in Q4, a marginal full-year gain of about 0.7%. Seasonal antibiotic demand cycles and 6-APA fermentation cost swings created the characteristic quarterly oscillation throughout the year.
US prices fell from about USD 45.5/KG in Q1 2025 to USD 44.8/KG by Q4, a decline of 1.5%. Alternating respiratory infection season demand cycles and adequate 6-APA supply maintained modest downward pressure through the year.
Chinese prices firmed from roughly USD 28.0/KG in Q1 2025 to USD 28.6/KG by Q4, a gain of 2.1%. Growing domestic and export pharmaceutical demand drove the modest firming. China held the lowest price level throughout the year.
German prices fell from about USD 55.0/KG in Q1 2025 to USD 54.2/KG by Q4, a decline of 1.5%. Post-winter antibiotic demand moderation and competitive Chinese API import pricing maintained modest downward pressure.
Indian prices firmed from roughly USD 40.5/KG in Q1 2025 to USD 41.2/KG by Q4, a gain of 1.7%. Growing domestic pharmaceutical formulation and veterinary demand supported the consistent firming through the year.
Expert Market Research: Your Source for Real-Time Ampicillin Price Intelligence
Expert Market Research tracks ampicillin prices continuously across every major producing and consuming region. The team traces causation through 6-APA fermentation substrate and phenylglycine synthesis economics, seasonal antibiotic demand cycles, and regional semi-synthesis capacity. Contact Expert Market Research today for ampicillin pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Pharmaceutical formulations for oral and parenteral treatment of bacterial infections in the respiratory tract, urinary tract, gastrointestinal system, and skin take the largest share. Veterinary antibiotic livestock treatment, ampicillin-sulbactam hospital combination products, and generic pharmaceutical manufacturing for emerging markets also consume significant volumes.
The Q2 2026 average was USD 47.9/KG in the United States, USD 30.5/KG in China, USD 58.0/KG in Germany, and USD 44.1/KG in India. Germany remains the highest-priced market.
The global average rose from USD 38.50/KG in Q1 to about USD 41.58/KG in Q2, a gain of around 8.0%. Spring respiratory infection season demand and firmer 6-APA fermentation costs drove the H1 2026 surge.
Seasonal respiratory and urinary infection prevalence cycles created alternating quarterly pharmaceutical procurement patterns. Post-winter and post-holiday procurement moderation created Q1 and Q3 dips while infection season restocking created Q4 and Q2 upticks.
The global average is expected in the USD 42.00 to 46.50/KG range for H2 2026, with continued firming as 6-APA fermentation costs stay elevated and pharmaceutical and veterinary antibiotic demand grows across emerging markets.
Germany sits highest on 6-APA and energy costs, the United States and India hold a firm middle on pharmaceutical and veterinary demand, and China prices lowest on large domestic semi-synthesis capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to 6-APA fermentation substrate and phenylglycine synthesis costs, seasonal respiratory infection demand cycles, and veterinary antibiotic sector procurement. Chinese API production discipline and corn steep liquor fermentation substrate costs are key signals.
Asia Pacific leads with China holding the largest 6-APA fermentation and ampicillin semi-synthesis capacity, followed by India and Europe. Any 6-APA or phenylglycine cost shift ripples across ampicillin markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time pharmaceutical and veterinary formulation contracts around seasonal infection demand cycles, build cover when 6-APA signals tightening, and monitor corn steep liquor and fermentation substrate cost trends as the primary upstream signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.